Royal London Hospital Embraces 'X-Factor' Concept

Carestream HealthCarestream Health has been awarded the contract to supply 5 DRX-Revolution mobile units to the new Royal London Hospital, part of Barts Health NHS Trust in London, which first opened its doors to the public in December 2011. Delivery is scheduled for June 2012 when the DRX-Revolution becomes available worldwide.

The order follows an investment by the hospital in 2010 of 8 DRX-Evolution DR rooms and builds on Carestream's 'X-Factor' concept, which enables DRX detectors to be shared across multiple X-ray systems. For example, a detector can be used in a mobile unit for early morning hospital rounds and then moved to a general radiology room. DRX detectors can also move from day use in general radiology rooms to mobile systems that serve the emergency department at night.

"The concept of sharing detectors was very attractive to us as we could utilise the 16 DRX-1 detectors already onsite for the DRX-Evolution rooms," said Matt Trevail, Operational Lead Radiographer at the Royal London Hospital. "As a consequence we ordered 5 DRX-Revolutions but only 3 DRX-1 detectors, which represented a significant cost saving."

The exceptional flexibility and image quality offered by the DRX family of digital X-ray systems makes these solutions an ideal fit for general radiography exams including orthopedic, trauma and pediatric as well as other specialty care environments.

"There were a number of features that we particularly liked on the DRX-Revolution, added Matt Trevail. "The graphic user interface is identical to the Evolution systems already operational at the hospital so minimal training will be necessary and the image processing is also the same to achieve consistency of imaging across all systems. Also, the collapsible tube column allows great visibility when being wheeled by radiographers and the tube alignment ensures that it is centred and angled correctly, even though the cassette and grid are not actually visible to the radiographer. This will help us achieve a high quality images and reduce the need for retakes."

The DRX-Revolution system shares the same DRX-1/DRX-1C wireless detectors as the rest of Carestream's DRX family that includes: CARESTREAM DRX-1 System, CARESTREAM DRX-Mobile Retrofit Kit, CARESTREAM DRX-Evolution modular DR suite, CARESTREAM DRX-Transportable System; and CARESTREAM DRX-Ascend System.

Related news articles:

About Carestream Health
Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for life science research and drug discovery/development; X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...